Calendar

Week of Apr 13, 2026

Apr 15, 2026recall87d agoFagron Compounding Services recall (Cls II)Baxter Healthcare Corp

norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-466-05, Unit of Sale NDC Number: 65219-466-60. — Reason: Lack of Assurance of Sterility — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-02. — Reason: Lack of Assurance of Sterility — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by: Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Sale NDC Number: 17271-701-05. — Reason: Lack of Assurance of Sterility — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack). — Reason: Superpotent and Subpotent — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoFagron Compounding Services recall (Cls II)Revalesio Corp

Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01 — Reason: Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoGE Healthcare Ireland Limited recall (Cls II)Amneal Pharmaceuticals, Inc.

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63. — Reason: Presence of particulate matter — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack). — Reason: Superpotent and Subpotent — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoFresenius Kabi USA, LLC recall (Cls II)Fresenius Kabi USA LLC

0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Becton Drive, Franklin Lakes, NJ 07417, Distributed by BD, Manufactured by Fresenius Kabi, Unit of Sale NDC Number: 17271-701-07. — Reason: Lack of Assurance of Sterility — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026recall87d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1 safety needle, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-870-67 — Reason: Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. — Status: Ongoing

full page →fda recalls ↗

Apr 15, 2026grant87d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Project 4New York University

AI grant. $344,099. PI: Vasishta Tatapudi

Week of Apr 13, 2026